Sara Huerta‐Yépez

Author

Sara Huerta‐Yépez

Hospital Infantil de México Federico Gómez ORCID

Also Known As

Gabriela Antonio-Andres and Sara Huerta-Yepez, Nayer Seyfizadeh, S HUERTAYEPEZ, S Huerta-Yepez, S. HUERTA-YEPEZ, S. Huerta-Yepez, S. Huerta‐Yepez, SARA HUERTA-YEPEZ, Sara Huerta Yepez, Sara Huerta Yépez

254

Publications

5.1K

Citations

H-Index

155

Concepts

All Affiliations

Hospital Infantil de México Federico Gómez University of California, Los Angeles Universidad Nacional Autónoma de México UCLA Jonsson Comprehensive Cancer Center Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

About

Sara Huerta‐Yépez is an author at Hospital Infantil de México Federico Gómez specializing in medicine, tumor biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	45	2.2K
2	Health Sciences	4	4	359
3	Natural Sciences	3	3	164
4	Engineering	2	2	68
5	Public Health	2	2	120

Sara Huerta‐Yépez

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Ali R. Jazirehi, Sara Huerta‐Yépez, Genhong Cheng, PubMed ApoptosisImmunologyCell DeathImmunotherapyDrug Resistance	2005	178
Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression Sara Huerta‐Yépez, Mario I. Vega, Ali R. Jazirehi, Oncogene Trail-mediated ApoptosisNitric OxideMedicineApoptosisCancer Cell Biology	2004	164
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1 Stavroula Baritaki, Sara Huerta‐Yépez, Toshiyuki Sakai, Molecular Cancer Therapeutics	2007	145
Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) Inhibits the Constitutive Nuclear Factor-κB Signaling Pathway in Non-Hodgkin's Lymphoma B-Cell Lines: Role in Sensitization to Chemotherapeutic Drug-induced Apoptosis Ali R. Jazirehi, Sara Huerta‐Yépez, Genhong Cheng, Cancer Research ApoptosisImmune RegulationImmunologyCell DeathImmunotherapeutics	2005	142
Rituximab-Induced Inhibition of YY1 and Bcl-xL Expression in Ramos Non-Hodgkin’s Lymphoma Cell Line via Inhibition of NF-κB Activity: Role of YY1 and Bcl-xL in Fas Resistance and Chemoresistance, Respectively Mario I. Vega, Ali R. Jazirehi, Sara Huerta‐Yépez, The Journal of Immunology	2005	127
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer Stavroula Baritaki, Sara Huerta‐Yépez, Anna Sahakyan, Cell Cycle Nitric OxideNitric Oxide-mediated InhibitionCancer BiologyTumor BiologyTranscriptional Regulation	2010	111
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis Mario I. Vega, Sara Huerta‐Yépez, Ali R. Jazirehi, Oncogene ApoptosisImmunologyCell DeathB-nhl Cell LinesImmune Checkpoint Inhibitor	2005	101
Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation Fumiya Hongo, Hermes Garbán, Sara Huerta‐Yépez, Biochemical and Biophysical Research Communications Transcriptional RegulationSystems BiologyReactive Nitrogen SpecieNatural SciencesGene Expression	2005	100
Hypoxia Inducible Factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis Sara Huerta‐Yépez, Guillermina Baay-Guzmán, Ilona G. Bebenek, Allergy	2011	97
C-Phycocyanin prevents cisplatin-induced nephrotoxicity through inhibition of oxidative stress Berenice Fernández-Rojas, Omar Noel Medina‐Campos, Rogélio Hernández‐Pando, Food & Function	2014	89

Page 1